Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
- PMID: 10763820
- DOI: 10.1038/sj.onc.1203460
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
Abstract
Centrosome hyperamplification and the consequential mitotic defects contribute to chromosome instability in cancers. Loss or mutational inactivation of p53 has been shown to induce chromosome instability through centrosome hyperamplification. It has recently been found that Cdk2-cyclin E is involved in the initiation of centrosome duplication, and that constitutive activation of Cdk2-cyclin E results in the uncoupling of the centrosome duplication cycle and the DNA replication cycle. Cyclin E overexpression and p53 mutations occur frequently in tumors. Here, we show that cyclin E overexpression and loss of p53 synergistically increase the frequency of centrosome hyperamplification in cultured cells as well as in tumors developed in p53-null, heterozygous, and wildtype mice. Through examination of cells derived from Waf1-null mice, we further found that Waf1, a potent inhibitor of Cdk2-cyclin E and a major target of p53's transactivation function, is involved in coordinating the initiation of centrosome duplication and DNA replication, suggesting that Waf1 may act as a molecular link between p53 and Cdk2-cyclin E in the control of the centrosome duplication cycle.
Similar articles
-
Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.Oncogene. 2001 May 31;20(25):3173-84. doi: 10.1038/sj.onc.1204424. Oncogene. 2001. PMID: 11423967
-
Cyclin-dependent kinase control of centrosome duplication.Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2817-22. doi: 10.1073/pnas.96.6.2817. Proc Natl Acad Sci U S A. 1999. PMID: 10077594 Free PMC article.
-
Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.Oncogene. 1999 Oct 7;18(41):5611-9. doi: 10.1038/sj.onc.1202945. Oncogene. 1999. PMID: 10523840
-
Cell cycle: driving the centrosome cycle.Curr Biol. 1999 Jun 17;9(12):R449-52. doi: 10.1016/s0960-9822(99)80279-6. Curr Biol. 1999. PMID: 10375518 Review.
-
P53, cyclin-dependent kinase and abnormal amplification of centrosomes.Biochim Biophys Acta. 2008 Sep;1786(1):15-23. doi: 10.1016/j.bbcan.2008.04.002. Epub 2008 Apr 22. Biochim Biophys Acta. 2008. PMID: 18472015 Free PMC article. Review.
Cited by
-
The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer.J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):203-12. doi: 10.1023/a:1011312808421. J Mammary Gland Biol Neoplasia. 2001. PMID: 11501580 Review.
-
Centrosomes and myeloma; aneuploidy and proliferation.Environ Mol Mutagen. 2009 Oct;50(8):697-707. doi: 10.1002/em.20528. Environ Mol Mutagen. 2009. PMID: 19739237 Free PMC article. Review.
-
Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.BMC Cell Biol. 2010 Jan 14;11:2. doi: 10.1186/1471-2121-11-2. BMC Cell Biol. 2010. PMID: 20070914 Free PMC article.
-
Keep Calm and Carry on with Extra Centrosomes.Cancers (Basel). 2022 Jan 17;14(2):442. doi: 10.3390/cancers14020442. Cancers (Basel). 2022. PMID: 35053604 Free PMC article. Review.
-
A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy.Curr Cancer Drug Targets. 2004 Feb;4(1):65-75. doi: 10.2174/1568009043481669. Curr Cancer Drug Targets. 2004. PMID: 14965268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
